Table 2.

Triglyceride (TG) content in blood samples.

Group	0D	6D	12D	18D	24D	30D	36D	42D
A	68.64 ± 17.17	122.1 ± 25.29	105.2 ± 37.06	97.09 ± 23.32	50.54 ± 13.77	60.36 ± 18.54	136.2 ± 44.40	94.54 ± 27.69
B	102.0 ± 25.19	196.8 ± 46.82***	28.80 ± 13.21***	51.08 ± 14.03***	35.40 ± 8.746**	34.89 ± 11.52**	80.00 ± 9.212**	66.00 ± 28.79*
C	76.63 ± 22.78#	157.6 ± 28.75∗∗, #	23.09 ± 2.023***	44.27 ± 10.29***	37.27 ± 12.58*	50.82 ± 18.25#	101.4 ± 37.04	79.64 ± 20.25
D	76.45 ± 18.23#	175.4 ± 46.39**	23.00 ± 1.907***	36.91 ± 9.268∗∗∗, #	34.67 ± 6.856**	47.88 ± 18.66	77.00 ± 14.70**	71.88 ± 19.09
E	94.33 ± 34.39*	148.4 ± 47.49#	22.42 ± 1.886***	31.60 ± 17.88∗∗∗, ##	37.20 ± 11.71*	41.00 ± 19.05*	84.22 ± 19.76**	72.56 ± 14.43*
F	57.36 ± 18.91###,†	104.1 ± 35.60###,††	55.00 ± 15.27∗∗∗, ###,†††	31.89 ± 8.978∗∗∗, ##,†	39.91 ± 14.88	41.78 ± 16.27*	72.44 ± 19.75∗∗∗,†	78.11 ± 12.92
G	56.00 ± 15.42###,††	144.1 ± 70.24#	46.45 ± 9.903∗∗∗, ##,†††	28.00 ± 13.03∗∗∗, ###	22.45 ± 7.634∗∗∗, ##,††	47.10 ± 11.31#	78.00 ± 31.65**	71.14 ± 15.34
H	54.73 ± 15.94###,††	203.7 ± 63.82∗∗∗,†	64.73 ± 15.97∗∗, ###,†††	29.45 ± 9.136∗∗∗, ###	26.18 ± 5.134∗∗∗, ##,†	52.09 ± 22.06#	101.1 ± 38.43	88.82 ± 20.89
I	47.08 ± 9.615∗∗, ###	139.4 ± 39.37##	44.00 ± 12.40∗∗∗, #	21.91 ± 3.360∗∗∗, ###	27.09 ± 6.188∗∗∗, #	34.18 ± 11.12***	93.91 ± 24.76*	86.18 ± 32.54
J	93.42 ± 37.48	119.3 ± 52.07###	34.08 ± 18.81***	31.64 ± 11.66∗∗∗, ###	41.45 ± 12.39	32.54 ± 4.034***	83.82 ± 26.78**	85.22 ± 22.16

Triglyceride (TG) contents were assayed by assay kits as described in the text.

Values are mean ± SD (n = 12) and expressed in mg/dL.

The * indicates a significant difference compared with control group, *P < 0.05, **P < 0.01, ***P < 0.001.

The ^# indicates a significant difference compared with model group, ^# P < 0.05, ^## P < 0.01, ^### P < 0.001.

The ^† indicates a significant difference compared with PMR group (same dosage level, F compared with C, G compared to D, H compared to E), ^† P < 0.05, ^†† P < 0.01, ^††† P < 0.001.